Scarica l'app Stockscreener
135.10
2.43%
3.305
Precedente Chiudi:
$131.80
Aprire:
$131.78
Volume 24 ore:
173.76K
Relative Volume:
0.24
Capitalizzazione di mercato:
$8.20B
Reddito:
$3.99B
Utile/perdita netta:
$463.16M
Rapporto P/E:
19.03
EPS:
7.1
Flusso di cassa netto:
$1.10B
1 W Prestazione:
+4.18%
1M Prestazione:
+5.68%
6M Prestazione:
+8.02%
1 anno Prestazione:
+23.82%
Intervallo 1D:
$131.76
$135.37
Intervallo di 1 settimana:
$125.78
$135.37
Portata 52W:
$95.49
$148.06
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Nome
Jazz Pharmaceuticals Plc
Settore
Industria
Telefono
353-1-634-7800
Indirizzo
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Confronta JAZZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
135.10 | 7.99B | 3.99B | 463.16M | 1.10B | 7.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.99 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
608.50 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.88 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
768.60 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
343.08 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Iniziato | Deutsche Bank | Buy |
| 2025-03-07 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Iniziato | Goldman | Buy |
| 2024-01-03 | Iniziato | Robert W. Baird | Outperform |
| 2023-11-27 | Downgrade | UBS | Buy → Neutral |
| 2023-09-29 | Iniziato | Raymond James | Mkt Perform |
| 2023-06-12 | Ripresa | Wells Fargo | Equal Weight |
| 2022-12-09 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-06-14 | Iniziato | UBS | Buy |
| 2022-04-06 | Downgrade | Goldman | Buy → Neutral |
| 2021-11-19 | Ripresa | Goldman | Buy |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-10-05 | Iniziato | Citigroup | Buy |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2021-05-19 | Ripresa | JP Morgan | Overweight |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-02-05 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-14 | Downgrade | Goldman | Neutral → Sell |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-08-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Iniziato | Goldman | Neutral |
| 2019-08-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2018-12-14 | Iniziato | Wolfe Research | Peer Perform |
| 2018-11-08 | Reiterato | B. Riley FBR | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2018-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Reiterato | H.C. Wainwright | Neutral |
| 2018-03-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
What MACD and RSI say about Jazz Pharmaceuticals plcShare Buyback & Consistent Growth Equity Picks - newser.com
Will Jazz Pharmaceuticals plc stock rally after Fed decisionsRisk Management & Consistent Profit Alerts - newser.com
Park Avenue Securities LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Will Jazz Pharmaceuticals plc (J7Z) stock remain on Wall Street radarMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Jazz Pharmaceuticals plc stock keep outperforming rivals2025 Key Highlights & Reliable Price Breakout Signals - newser.com
Will Jazz Pharmaceuticals plc (J7Z) stock announce special dividendOptions Play & Real-Time Volume Trigger Notifications - newser.com
Is Jazz Pharmaceuticals plc a candidate for recovery playJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com
Jazz Pharmaceuticals (JAZZ) Stock Analysis: 47% Potential Upside Catches Investor Attention - DirectorsTalk Interviews
Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 47% Upside Potential Beckons Investors - DirectorsTalk Interviews
State of Alaska Department of Revenue Boosts Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Why Jazz Pharmaceuticals plc (J7Z) stock could be top winner2025 Big Picture & AI Forecasted Stock Moves - newser.com
What analysts say about Jazz Pharmaceuticals plc stockFederal Reserve Announcements & Small Investment Trading Tips - earlytimes.in
Jazz Pharmaceuticals plc J7Z Stock Analysis and ForecastTechnical Resistance Breaks & Low Cost Wealth Plans - earlytimes.in
What analysts say about Jazz Pharmaceuticals plc J7Z stockRSI Overbought/Oversold & Free Daily Stock Hotspot Analysis - earlytimes.in
Are Jazz Pharmaceuticals Shares Set for a Rebound After Recent Drug Approval in 2025? - simplywall.st
Piper Sandler Reaffirms Jazz Pharmaceuticals (JAZZ) Price Target Ahead of Trial Data - MSN
What drives Jazz Pharmaceuticals plc stock priceDividend Stock Watch & Exceptional Capital Investment - Early Times
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
EClinical Solutions Explores Data Intelligence in Modern Clinical Trials at ENGAGE 2025 - MarketScreener
JAZZ: Morgan Stanley Raises Price Target to $167, Maintains Over - GuruFocus
Affinity Wealth Management LLC Purchases New Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
United States Myelodysplastic Syndrome Treatment Market - openPR.com
Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - MSN
Jazz Pharmaceuticals Secures Dismissal of Patent Fraud Lawsuit - Bloomberg Law News
Jazz Pharmaceuticals Announces Promising Xywav Data: Why I Assign A BUY Rating - Seeking Alpha
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment - The Globe and Mail
Morgan Stanley Issues Positive Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Perpetual Ltd - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Bought by CX Institutional - MarketBeat
Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval - Yahoo Finance
Jazz Pharmaceuticals stock price target raised to $167 from $163 at Morgan Stanley - Investing.com UK
Jazz Pharmaceuticals (JAZZ): Assessing Valuation Following Fresh Xywav Clinical Data at Leading Medical Conferences - simplywall.st
Wedmont Private Capital Decreases Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals stock hits 52-week high of $134.24 - MSN
Swedbank AB Lowers Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz pharma presents new data on narcolepsy and hypersomnia treatment - Investing.com
Jazz Pharmaceuticals presents Xywav data at medical conferences - StreetInsider
Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses - PR Newswire
United States Narcolepsy Therapeutics Market Trends & Growth - openPR.com
Voya Investment Management LLC Acquires 22,628 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
How NCCN Endorsement of Modeyso May Shape Jazz Pharmaceuticals' (JAZZ) Rare Oncology Expansion - simplywall.st
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by MassMutual Private Wealth & Trust FSB - MarketBeat
Strs Ohio Purchases Shares of 16,445 Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Lingohr Asset Management GmbH Sells 37,288 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals Plc Azioni (JAZZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):